{
  "actions": [
    {
      "acted_at": "2025-03-03",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2025-03-03",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s822-119",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "Referred To"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    }
  ],
  "congress": "119",
  "cosponsors": [
    {
      "bioguide_id": "W000437",
      "district": null,
      "name": "Wicker, Roger F.",
      "original_cosponsor": true,
      "sponsored_at": "2025-03-03",
      "state": "MS",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2025-03-03",
  "number": "822",
  "official_title": "A bill to amend the Federal Food, Drug, and Cosmetic Act to establish a process for science-focused drug development meetings led by the Reagan-Udall Foundation for the Food and Drug Administration with respect to drugs for rare diseases and conditions, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": null,
  "sponsor": {
    "bioguide_id": "K000367",
    "district": null,
    "name": "Klobuchar, Amy",
    "state": "MN",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2025-03-03",
  "subjects": [],
  "subjects_top_term": null,
  "summary": null,
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to amend the Federal Food, Drug, and Cosmetic Act to establish a process for science-focused drug development meetings led by the Reagan-Udall Foundation for the Food and Drug Administration with respect to drugs for rare diseases and conditions, and for other purposes.",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to amend the Federal Food, Drug, and Cosmetic Act to establish a process for science-focused drug development meetings led by the Reagan-Udall Foundation for the Food and Drug Administration with respect to drugs for rare diseases and conditions, and for other purposes.",
      "type": "official"
    }
  ],
  "updated_at": "2025-03-04T11:56:17Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/119/s/BILLSTATUS-119s822.xml"
}